No Data
CANSINOBIO (06185.HK) will release its Earnings Reports on April 29.
$CANSINOBIO (06185.HK) will release its Earnings Reports on April 29, and investors are advised to pay attention. How was the previous performance? 2024 Q1 revenue was 0.114 billion yuan, Net income was -0.175 billion yuan, and EPS was -0.69 yuan. Futubull reminder: 1. There are no strict regulations on the accounting year division time for Hong Kong and U.S. listed companies; it is entirely decided by the company itself. Therefore, each Earnings Reports period can be treated as the company's annual report deadline, rather than following the natural year as the fiscal year. 2. Generally, the company will hold an Earnings Reports meeting on or around the date of the aforementioned Earnings Reports release.
CanSino Biologics Narrows Loss in Q1
Hong Kong stock market movement | CANSINOBIO (06185) surged over 10% during trading, with the market share of Mankai steadily increasing, and first-quarter revenue rose by 20% year-on-year.
CANSINOBIO (06185) rose more than 10% during the day. As of the time of reporting, it has increased by 9.38%, reaching HKD 33.25, with a transaction volume of HKD 48.451 million.
Cansino: First Quarter Report 2025
2025 First Quarter Report
Express News | CanSino Biologics Inc - Qtrly Operating Revenue RMB137.2 Mln
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}